TYK Medicines, Inc. (H shares, stock code 02410) filed its Monthly Return for the period ended 31 July 2026, confirming that both registered and issued share capital remained stable during the month.

The registered share capital stood at RMB 380.07 million, corresponding to 380.07 million H shares with a par value of RMB 1 each. No increases, decreases, or cancellations were recorded, and the company held no treasury shares at month-end.

TYK Medicines also affirmed compliance with the Hong Kong Stock Exchange’s minimum public-float requirement of 25 percent for its H-share class.

The filing indicated no activity under share option schemes, warrants, convertibles, or other equity-linked instruments. The return was submitted by Executive Director, Chairman and Chief Executive Officer Wu Yusheng on 05 August 2026.